Gastroenterology

New real-world data suggest early lactate clearance can predict massive transfusion needs in upper gastrointestinal bleeding, improving early risk stratification when combined with the Glasgow-Blatchford score.

A large network meta-analysis finds dual therapy for Helicobacter pylori offers comparable eradication rates with fewer side effects and better compliance than triple or quadruple regimens.

Real-world data show how microbiological findings and patient factors can guide empirical antibiotic choice in acute cholangitis, supporting carbapenem-sparing strategies in selected patients.

Real-world data show distinct determinants of health-related quality of life in Crohn’s disease and ulcerative colitis, highlighting phenotype-specific roles of inflammation, imaging findings, treatment burden, and modifiable risk factors.

A decade-long retrospective study shows IgG4-related cholangitis responds well to steroids, with low mortality and no progression to cholangiocarcinoma.

Integrated structural and functional MRI identifies brain-based biomarkers that distinguish active from remissive Crohn’s disease and correlate with gut inflammation.

New research shows resilience partially offsets financial toxicity and improves quality of life in patients with primary liver cancer, highlighting the importance of psychosocial support.

Colonic stent placement as a bridge to surgery shows similar survival to emergency resection while reducing stoma rates in obstructive colorectal cancer.